Frei test
Frei test is a historical diagnostic test that was used to identify Lymphogranuloma venereum (LGV), a sexually transmitted infection caused by certain types of the bacterium Chlamydia trachomatis. The test was named after the German dermatologist Fritz Schaudinn who developed it in the early 20th century. The Frei test was one of the first attempts to use an intradermal test for the diagnosis of a specific infectious disease, marking a significant advancement in the field of infectious diseases and immunology at the time.
Procedure[edit]
The Frei test involved the intradermal injection of a heat-inactivated material, known as Frei antigen, which was derived from the lymph nodes of patients with LGV. The test was considered positive if, after 48 to 72 hours, the injection site exhibited a localized inflammatory reaction, typically characterized by redness, swelling, and induration. A positive Frei test was indicative of a current or past infection with LGV.
Historical Context[edit]
During the early to mid-20th century, the Frei test was a significant diagnostic tool for LGV, especially in areas where the disease was endemic. However, the test had several limitations, including the potential for false-positive reactions and the risk of transmitting other infectious agents through the use of biological material from infected individuals. With the advent of more accurate and safer diagnostic methods, such as nucleic acid amplification tests (NAATs) and serological testing, the Frei test has become obsolete and is no longer used in clinical practice.
Impact and Legacy[edit]
The development and use of the Frei test represent an important era in the history of infectious disease diagnosis. It highlighted the need for specific diagnostic tests to manage sexually transmitted infections effectively and paved the way for the development of modern diagnostic techniques. Despite its limitations and eventual obsolescence, the Frei test contributed to the understanding of LGV and the importance of targeted diagnostic methods in controlling infectious diseases.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian